Amicus Therapeutics
FOLD
$10.28
Share price
1.08%
Change (1 day)
-10.92%
Change (1 year)
Categories
Amicus Therapeutics (FOLD) Fails to deliver data
Key failure to deliver metrics for Amicus Therapeutics :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $1.7 M
- Last year FTD volume: $4.65 M
Failures to deliver for Amicus Therapeutics (FOLD) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Amicus Therapeutics (FOLD) - since 2013
Volume in USD (price x number of shares), data since 2013Amicus Therapeutics (FOLD) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $1.67 M | -55.4% |
| 2023 | $3.74 M | -55.9% |
| 2022 | $8.49 M | 17.92% |
| 2021 | $7.2 M | -82.17% |
| 2020 | $40.39 M | -25.02% |
| 2019 | $53.87 M | 65.54% |
| 2018 | $32.54 M | 14.55% |
| 2017 | $28.41 M | -25.82% |
| 2016 | $38.3 M | -25.86% |
| 2015 | $51.66 M | 162.72% |
| 2014 | $19.66 M | 1873.58% |
| 2013 | $0.99 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Novo Nordisk NVO | $51.01 M | $0.12 B | 🇩🇰 Denmark |
 Biogen BIIB | $17.8 M | $72.14 M | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Lexicon Pharmaceuticals
LXRX | $14.09 M | $23.42 M | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $3.36 M | $8.49 M | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $2.19 M | $7.77 M | 🇺🇸 USA |